Search research articles
Contact Us
Filters
Showing results (151-160 of 185) with videos related to
Page
of 19
Sort By:
Cancer Biology & Medicine
|
March 12, 2025
Continuous R-DA-EDOCH alternated with high-dose Ara-C induces deep remission and overcomes high-risk factors in young patients with newly diagnosed mantle cell lymphoma
Yi Wang, Yuting Yan, Dandan Shan, et al.
Medscience
|
June 2, 2026
Obinutuzumab plus bendamustine as first-line therapy for indolent B-cell lymphomas: a prospective multicenter open-label study
Yuting Yan, Xinyang Hu, Xiuhua Sun, et al.
Blood Science (Baltimore, Md.)
|
May 25, 2023
Benefit of rituximab maintenance is associated with Follicular Lymphoma International Prognostic Index in patients with follicular lymphoma
Ru Li, Tingyu Wang, Rui Lyv, et al.
Eclinicalmedicine
|
January 7, 2026
Ibrutinib alternating with three cycles of interval fludarabine, cyclophosphamide, and rituximab (FCR) in adults with untreated chronic lymphocytic leukaemia as time-limited regimen: a single-arm, multicentre phase 2 trial in China
Tingyu Wang, Yuting Yan, Hui Wang, et al.
Annals of Hematology
|
February 25, 2025
The optimal time and clinical implications of measurable residual disease detection in mantle cell lymphoma
Yuting Yan, Yanshan Huang, Ying Yu, et al.
Research (Washington, D.C.)
|
August 22, 2024
Microsecond-Scale Transient Thermal Sensing Enabled by Flexible Mo<sub>1-x</sub>W<sub>x</sub>S<sub>2</sub> Alloys
Weiwei Li, Lingyan Kong, Manzhang Xu, et al.
Oncotarget
|
February 10, 2018
Del17p does not always significantly influence the survival of B-cell chronic lymphoproliferative disorders
Shuhua Yi, Zengjun Li, Dehui Zou, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 27, 2026
Phase II Study of BCMA Chimeric Antigen Receptor T-Cell Therapy in Patients With Newly Diagnosed Multiple Myeloma Ineligible for or Not Proceeding to Autologous Stem-Cell Transplantation (CAREMM-001)
Wenqiang Yan, Chenxing Du, Rui Lv, et al.
Current Research in Immunology
|
May 2, 2022
Physiological substrates and ontogeny-specific expression of the ubiquitin ligases MARCH1 and MARCH8
Patrick Schriek, Haiyin Liu, Alan C Ching, et al.
Blood Advances
|
March 5, 2026
Proteogenomic features define subtypes of mantle cell lymphoma
Yuting Yan, Weihao Chen, Xinzhou Ge, et al.
Page
of 19
Search research articles
Search
Showing results (151-160 of 185) with videos related to
Sort By:
Page
of 19
Cancer Biology & Medicine
|
March 12, 2025
Continuous R-DA-EDOCH alternated with high-dose Ara-C induces deep remission and overcomes high-risk factors in young patients with newly diagnosed mantle cell lymphoma
Yi Wang, Yuting Yan, Dandan Shan, et al.
Medscience
|
June 2, 2026
Obinutuzumab plus bendamustine as first-line therapy for indolent B-cell lymphomas: a prospective multicenter open-label study
Yuting Yan, Xinyang Hu, Xiuhua Sun, et al.
Blood Science (Baltimore, Md.)
|
May 25, 2023
Benefit of rituximab maintenance is associated with Follicular Lymphoma International Prognostic Index in patients with follicular lymphoma
Ru Li, Tingyu Wang, Rui Lyv, et al.
Eclinicalmedicine
|
January 7, 2026
Ibrutinib alternating with three cycles of interval fludarabine, cyclophosphamide, and rituximab (FCR) in adults with untreated chronic lymphocytic leukaemia as time-limited regimen: a single-arm, multicentre phase 2 trial in China
Tingyu Wang, Yuting Yan, Hui Wang, et al.
Annals of Hematology
|
February 25, 2025
The optimal time and clinical implications of measurable residual disease detection in mantle cell lymphoma
Yuting Yan, Yanshan Huang, Ying Yu, et al.
Research (Washington, D.C.)
|
August 22, 2024
Microsecond-Scale Transient Thermal Sensing Enabled by Flexible Mo<sub>1-x</sub>W<sub>x</sub>S<sub>2</sub> Alloys
Weiwei Li, Lingyan Kong, Manzhang Xu, et al.
Oncotarget
|
February 10, 2018
Del17p does not always significantly influence the survival of B-cell chronic lymphoproliferative disorders
Shuhua Yi, Zengjun Li, Dehui Zou, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 27, 2026
Phase II Study of BCMA Chimeric Antigen Receptor T-Cell Therapy in Patients With Newly Diagnosed Multiple Myeloma Ineligible for or Not Proceeding to Autologous Stem-Cell Transplantation (CAREMM-001)
Wenqiang Yan, Chenxing Du, Rui Lv, et al.
Current Research in Immunology
|
May 2, 2022
Physiological substrates and ontogeny-specific expression of the ubiquitin ligases MARCH1 and MARCH8
Patrick Schriek, Haiyin Liu, Alan C Ching, et al.
Blood Advances
|
March 5, 2026
Proteogenomic features define subtypes of mantle cell lymphoma
Yuting Yan, Weihao Chen, Xinzhou Ge, et al.
Page
of 19